iBio Inc is a biotechnology company. It is engaged in commercializing its proprietary platform technologies, iBioLaunch for vaccines and therapeutic proteins & iBioModulator for vaccine enhancement and developing select product candidates.
| Website: | www.ibioinc.com |
| Email: | ir@ibioinc.com |
| Main Phone: | +1 302 355-0650 |
| Address: | 600 Madison Avenue |
| Address 2: | Suite 1601 |
| State: | NY |
| City / Town: | New York |
| Country: | USA |
| Postal Code: | 10022-1737 |
| Exchange: | AMX |
| CEO: | Robert B. Kay |
| Employees: | 54 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
| Last Price 0.87 | Change $ -0.0015 | Change % -0.17 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask N/A | Ask Size 0.00 |
| Open 0.87 | High 0.90 | Low 0.85 | Prev Close 0.87 |
| Last Trade | Volume 128,328 | 52 Wk Hi 3.86 | 52 Wk Low 0.60 |
| Market Cap 16 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 18,336,792.00 | EPS (TTM) -1.44 | PE Ratio N/A | Exchange NYSE American |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 0 | 0 |
| Number of Buys | 0 | 0 |
| Number of Sells | 0 | 0 |
| Net Activity | 0 | 0 |
| Last 10 Buys | Shares |
|---|---|
| John D. McKey | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| John D. McKey | 1,000 |
| John D. McKey | 1,000 |
| John D. McKey | 1,000 |
| John D. McKey | 1,000 |
| John D. McKey | 1,000 |
| John D. McKey | 1,000 |
| John D. McKey | 1,000 |
| John D. McKey | 1,000 |
| John D. McKey | 1,000 |
| John D. McKey | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 3 | 3 | 3 | 3 |
| Low Target Price Estimate | 3 | 3 | 3 | 3 |
| Mean Target Price Estimate | 3 | 3 | 3 | 3 |
| Standard Deviation | 0 | 0 | 0 | 0 |
| Date of Most Recent Estimate | 02/19/13 | 02/19/13 | 02/19/13 | 02/19/13 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| FWP | Free Writing Prospectus | 24 | 2018-06-13 |
| S-1/A | Amendment to general form for registration of securities under the Securities Act of 1933 | 73 | 2018-06-11 |
| 8-K | Report of unscheduled material events or corporate changes. | 6 | 2018-06-08 |
| 8-K | Report of unscheduled material events or corporate changes. | 5 | 2018-06-08 |
| 8-K | Report of unscheduled material events or corporate changes. | 5 | 2018-05-31 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 58 | 2018-05-11 |
| S-1 | General form for registration of securities under the Securities Act of 1933 | 91 | 2018-05-02 |
| 8-K | Report of unscheduled material events or corporate changes. | 3 | 2018-04-25 |
| DEF 14A | Official notification to shareholders of matters to be brought to a vote (Proxy) | 23 | 2018-04-03 |
| PRE 14A | Preliminary proxy statement providing notification matters to be brought to a vote | 23 | 2018-03-21 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 0 | 0 | 0 | 1 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
